⌘K
Loading ticker…
PMGC Holdings Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, PMGC Holdings Inc. Common Stock (ELAB) has a 3-month relative strength percentile of 8 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 25. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 9.0%, relative volume 0.12×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
8 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
ELAB is in a stage 4 downtrend, week 12. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -42.6% / -97.8%.
Attention is elevated versus its own recent norm without the relative strength to match — the loud-but-lagging pattern. Worth a skeptical eye; not a short signal.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ELAB Jan avg: -42.75% median: -40.71% win: 0% σ: 18.52% n: 3 2023-11-22 → 2026-05-29 | ELAB Feb avg: -30.81% median: -27.19% win: 33% σ: 33.63% n: 3 2023-11-22 → 2026-05-29 | ELAB Mar avg: -21.09% median: -16.11% win: 0% σ: 23.69% n: 3 2023-11-22 → 2026-05-29 | ELAB Apr avg: -36.22% median: -50.54% win: 33% σ: 32.35% n: 3 2023-11-22 → 2026-05-29 | ELAB May avg: -14.20% median: -8.73% win: 0% σ: 12.08% n: 3 2023-11-22 → 2026-05-29 | ELAB Jun avg: -4.39% median: -4.39% win: 50% σ: 10.94% n: 2 2023-11-22 → 2026-05-29 (current) | ELAB Jul avg: -11.39% median: -11.39% win: 0% σ: 11.52% n: 2 2023-11-22 → 2026-05-29 | ELAB Aug avg: -32.70% median: -32.70% win: 0% σ: 14.45% n: 2 2023-11-22 → 2026-05-29 | ELAB Sep avg: -37.77% median: -37.77% win: 0% σ: 43.94% n: 2 2023-11-22 → 2026-05-29 | ELAB Oct avg: -8.46% median: -8.46% win: 50% σ: 28.93% n: 2 2023-11-22 → 2026-05-29 | ELAB Nov avg: -36.79% median: -17.35% win: 0% σ: 39.85% n: 3 2023-11-22 → 2026-05-29 | ELAB Dec avg: -31.79% median: -34.94% win: 33% σ: 42.01% n: 3 2023-11-22 → 2026-05-29 |